Paul Govern

silhouette of three men with guns
October 5, 2021

Breaking bad with Huntington’s disease

Illegal activities are a significant clinical problem in individuals with Huntington’s disease, highlighting the need for improved screening measures and protocols to guide patient management.

By Paul Govern
October 1, 2021

VUMC awarded $31.7 million to harmonize Alzheimer’s research data

Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.

By Paul Govern
Interventions such as daily spontaneous waking trials can help patients avoid injuries associated with intensive care.
September 30, 2021

AI predicts next-day delirium or coma in ICU patients

A team at Vanderbilt University Medical Center used machine learning to predict the likelihood of next-day brain function status changes in critical care patients.

By Paul Govern
Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.
September 23, 2021

Local family shines in campaign to establish ALS research program

Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

By Paul Govern
September 9, 2021

Froehler elected a second time to surgery society board

For a second consecutive year, Vanderbilt’s Michael Froehler, MD, PhD, has been elected a member of the board of directors of the Society of NeuroInterventional Surgery (SNIS).

By Paul Govern
September 2, 2021

Using billing codes to count cancers

The billing codes in electronic health records are useful for counting skin cancers over time — an important metric for cancer risk assessment and prevention.

By Paul Govern
September 2, 2021

Study shows gene-drug interactions are common

When a drug or combination of drugs causes different responses in different people, genetic variation is often at play. Pharmacogenomics, through discovery of genetic risk and use of clinical genotyping, aims to reduce trial-and-error approaches to drug prescribing.
By Paul Govern
August 26, 2021

One Hundred Oaks EVS staff at 500 injury-free days and counting

At Vanderbilt Health One Hundred Oaks, among the 40 full-time Aramark Corp. employees who work under contract to provide environmental services — EVS, an industry term for health care cleaning services — there has not been an injury requiring medical attention in more than 500 days.
By Paul Govern
August 12, 2021

Wanjalla honored by Doris Duke Foundation

Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.
By Paul Govern
August 12, 2021

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.
By Paul Govern
August 9, 2021

Sudden death from deep in the brain?

Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy.
By Paul Govern
July 29, 2021

Ground versus air to transport stroke patients studied

For patients in need of acute ischemic stroke treatment, air transport to Vanderbilt University Medical Center is apt to be quicker than ground transport for interhospital transfers of 40 miles or more and for direct-from-scene transfers of 28 miles or more.
By Paul Govern
1 … 17 18 19 20 21 … 52